Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@TohJah7809 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1428015800644816896.png) @TohJah7809 TohJah

TohJah posts on X about $twst, $zlab, meituan, china the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::1428015800644816896/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1428015800644816896/c:line/m:interactions.svg)

- X Week XXXXX -XX%
- X Month XXXXXX -XX%
- X Months XXXXXXX +38%
- X Year XXXXXXX +87%

### Mentions: XX [#](/creator/twitter::1428015800644816896/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1428015800644816896/c:line/m:posts_active.svg)

- X Week XX +9.10%
- X Month XX -XX%
- X Months XXX +4.30%
- X Year XXX +178%

### Followers: XXXXX [#](/creator/twitter::1428015800644816896/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1428015800644816896/c:line/m:followers.svg)

- X Week XXXXX no change
- X Month XXXXX +0.34%
- X Months XXXXX +17%
- X Year XXXXX +24%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1428015800644816896/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1428015800644816896/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1428015800644816896/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXX% [countries](/list/countries)  XXXX% [technology brands](/list/technology-brands)  XXXX% [finance](/list/finance)  XXXX% [cryptocurrencies](/list/cryptocurrencies)  XXXX% [travel destinations](/list/travel-destinations)  XXXX%

**Social topic influence**
[$twst](/topic/$twst) #12, [$zlab](/topic/$zlab) #6, [meituan](/topic/meituan) 2.44%, [china](/topic/china) 2.44%, [$pacb](/topic/$pacb) 2.44%, [$rxrx](/topic/$rxrx) 1.63%, [$absi](/topic/$absi) 1.63%, [$arkg](/topic/$arkg) #10, [$atai](/topic/$atai) #35, [$crbu](/topic/$crbu) XXXX%

**Top accounts mentioned or mentioned by**
[@twistbioscience](/creator/undefined) [@biotech2k1](/creator/undefined) [@joe80398726](/creator/undefined) [@3primeanalytica](/creator/undefined) [@biopharmiq](/creator/undefined) [@davidinglestv](/creator/undefined) [@ascptjournals](/creator/undefined) [@mdandersonnews](/creator/undefined) [@aacr](/creator/undefined) [@duedoctor](/creator/undefined) [@acquiredfm](/creator/undefined) [@cirakue](/creator/undefined) [@elilillyandco](/creator/undefined) [@timopler](/creator/undefined) [@jessiechimni](/creator/undefined) [@ceo_culley](/creator/undefined)

**Top assets mentioned**
[Twist Bioscience Corporation Common Stock (TWST)](/topic/$twst) [Pacific Biosciences of California, Inc. (PACB)](/topic/$pacb) [Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX)](/topic/$rxrx) [ATAI Life Sciences (ATAI)](/topic/$atai) [10x Genomics, Inc. Class A Common Stock (TXG)](/topic/$txg) [Tempus AI, Inc. Class A Common Stock (TEM)](/topic/$tem) [Schrodinger, Inc. Common Stock (SDGR)](/topic/$sdgr) [Pfizer, Inc. (PFE)](/topic/$pfe) [Vertex Protocol (VRTX)](/topic/$vrtx) [Amgen, Inc. (AMGN)](/topic/$amgn) [Revolution Medicines, Inc. Common Stock (RVMD)](/topic/$rvmd) [Synthetify (SNY)](/topic/$sny) [Illumina, Inc. (ILMN)](/topic/$ilmn)
### Top Social Posts [#](/creator/twitter::1428015800644816896/posts)
---
Top posts by engagements in the last XX hours

"Meituan (3690 HK): credit valuation after Q2 results"  
[X Link](https://x.com/TohJah7809/status/1695049961623453833) [@TohJah7809](/creator/x/TohJah7809) 2023-08-25T12:26Z 2060 followers, XXX engagements


"China tech credit research: Meituan 3690 HK"  
[X Link](https://x.com/TohJah7809/status/1774482779088343493) [@TohJah7809](/creator/x/TohJah7809) 2024-03-31T17:03Z 2060 followers, XXX engagements


"Ark's weekly bio commentaries: $AKRG $PACB $TXG $TEM $RXRX $ABSI $SDGR Techbio stocks rallied on FDA's animal testing news - guidelines updated to rely less on animal testing and more on AI organoids + international human data beginning w/ biologics e.g. monoclonal antibodies πŸ₯ΌπŸ”¬πŸ§«πŸ§ͺπŸ¦ πŸ§¬πŸ’»πŸ§‘πŸ”¬πŸ€’πŸŒ‘πŸ’‰πŸ©ΈπŸ©ΉπŸ’ŠπŸ˜·πŸ©ΊπŸ₯βš•"  
[X Link](https://x.com/TohJah7809/status/1910987450379591847) [@TohJah7809](/creator/x/TohJah7809) 2025-04-12T09:24Z 2059 followers, 1612 engagements


"$ZLAB TIVDAK (tisotumab vedotin-tftv) approved in HK  This is $GMAB and $PFE's ADC for recurrent or metastatic cervical cancer Approved by the FDA is the US in Apr 2024  Now approved in HK  Under review in mainland China  Zai Lab has exclusive license from Pfizer in Greater China (CN HK TW MO) πŸ₯ΌπŸ”¬πŸ§«πŸ§ͺπŸ¦ πŸ§¬πŸ’»πŸ§‘πŸ”¬πŸ€’πŸŒ‘πŸ’‰πŸ©ΈπŸ©ΉπŸ’ŠπŸ˜·πŸ©ΊπŸ₯βš•"  
[X Link](https://x.com/TohJah7809/status/1964253567008854316) [@TohJah7809](/creator/x/TohJah7809) 2025-09-06T09:05Z 2060 followers, XXX engagements


"Ark's weekly bio commentaries: $ARKG $QSI $RXRX $ABSI $PSNL $ATAI (next tweet) πŸ₯ΌπŸ”¬πŸ§«πŸ§ͺπŸ¦ πŸ§¬πŸ’»πŸ§‘πŸ”¬πŸ€’πŸŒ‘πŸ’‰πŸ©ΈπŸ©ΉπŸ’ŠπŸ˜·πŸ©ΊπŸ₯βš•"  
[X Link](https://x.com/TohJah7809/status/1980214459257008161) [@TohJah7809](/creator/x/TohJah7809) 2025-10-20T10:08Z 2059 followers, 1369 engagements


"Zai Lab partner news: Vertex kidney portfolio updates πŸ‘‡πŸ‘€ $VRTX $ZLAB πŸ₯ΌπŸ”¬πŸ§«πŸ§ͺπŸ¦ πŸ§¬πŸ’»πŸ§‘πŸ”¬πŸ€’πŸŒ‘πŸ’‰πŸ©ΈπŸ©ΉπŸ’ŠπŸ˜·πŸ©ΊπŸ₯βš•"  
[X Link](https://x.com/TohJah7809/status/1971862183199101229) [@TohJah7809](/creator/x/TohJah7809) 2025-09-27T08:59Z 2060 followers, XXX engagements


"@3primeAnalytica Heres a matcha shop in Japan: how does the price compare to London 🍡"  
[X Link](https://x.com/TohJah7809/status/1980156446575895038) [@TohJah7809](/creator/x/TohJah7809) 2025-10-20T06:17Z 2059 followers, XX engagements


"A few bios' anchor investors: $TWST: Artisan XXX% $RLAY: Point72 Commodore XXX% each $SANA: ARCH XX% Flagship XX% $FATE: Redmile XXXX% $CRBU: CEO Rachel X% 😍 $IPSC: Versant XX% $PACB: Madrone + Shimoda (Walmart scion) XXX% $ZLAB: Qiming X% πŸ₯ΌπŸ”¬πŸ§«πŸ§ͺπŸ¦ πŸ§¬πŸ’»πŸ§‘πŸ”¬πŸ€’πŸŒ‘πŸ’‰πŸ©ΈπŸ©ΉπŸ’ŠπŸ˜·πŸ©ΊπŸ₯βš•"  
[X Link](https://x.com/TohJah7809/status/1959280988758151580) [@TohJah7809](/creator/x/TohJah7809) 2025-08-23T15:46Z 2058 followers, 3075 engagements


"$ZLAB news from $AMGN: bemarituzumab (anti FGFR2b) combo w/ chemo for 1L gastric cancer: FORTITUDE-101 p3 trial completed Final analysis OS less than interim analysis πŸ˜±πŸ˜΅πŸ’« Zai Lab will wait for FORTITUDE-102 results: bemarituzumab + Nivolumab/ Opdivo + chemo combo (expected end 2025 or 2026 H1) $ZLAB stock -X% for the week: dipped on this news then partially bounced yesterday $AMGN flat for the week ( $XBI +6% 🦾) πŸ₯ΌπŸ”¬πŸ§«πŸ§ͺπŸ¦ πŸ§¬πŸ’»πŸ§‘πŸ”¬πŸ€’πŸŒ‘πŸ’‰πŸ©ΈπŸ©ΉπŸ’ŠπŸ˜·πŸ©ΊπŸ₯βš•"  
[X Link](https://x.com/TohJah7809/status/1964275859734647108) [@TohJah7809](/creator/x/TohJah7809) 2025-09-06T10:33Z 2058 followers, XXX engagements


"$TWST x Element Bio collab top-up πŸ‘‡πŸ‘€ πŸ₯ΌπŸ”¬πŸ§«πŸ§ͺπŸ¦ πŸ§¬πŸ’»πŸ§‘πŸ”¬πŸ€’πŸŒ‘πŸ’‰πŸ©ΈπŸ©ΉπŸ’ŠπŸ˜·πŸ©ΊπŸ₯βš•"  
[X Link](https://x.com/TohJah7809/status/1976968202451403156) [@TohJah7809](/creator/x/TohJah7809) 2025-10-11T11:08Z 2059 followers, XXX engagements


"$TWST Announces Publication in Science Examining Biosecurity Screening Practices in AI-assisted Protein Design πŸ₯ΌπŸ”¬πŸ§«πŸ§ͺπŸ¦ πŸ§¬πŸ’»πŸ§‘πŸ”¬πŸ€’πŸŒ‘πŸ’‰πŸ©ΈπŸ©ΉπŸ’ŠπŸ˜·πŸ©ΊπŸ₯βš•"  
[X Link](https://x.com/TohJah7809/status/1976969566833328396) [@TohJah7809](/creator/x/TohJah7809) 2025-10-11T11:14Z 2059 followers, XXX engagements


"The FDAs National Priority Voucher pilot X programmes πŸ‘‡πŸ½πŸ‘€ $SNY $RVMD πŸ₯ΌπŸ”¬πŸ§«πŸ§ͺπŸ¦ πŸ§¬πŸ’»πŸ§‘πŸ”¬πŸ€’πŸŒ‘πŸ’‰πŸ©ΈπŸ©ΉπŸ’ŠπŸ˜·πŸ©ΊπŸ₯βš•"  
[X Link](https://x.com/TohJah7809/status/1978973224357540242) [@TohJah7809](/creator/x/TohJah7809) 2025-10-16T23:55Z 2059 followers, XXX engagements


"China tech credit research:  Meituan (ticker: 3690 HK) $11.8b cash low gross leverage: 2.1x Stock trading at HK$114.7 US$92b market cap Largest food delivery + top X hotel & travel booking company in China Sub-HK$90-100 would be πŸ˜‹"  
[X Link](https://x.com/TohJah7809/status/1801915767325417748) [@TohJah7809](/creator/x/TohJah7809) 2024-06-15T09:52Z 2059 followers, XXX engagements


"My own narrative on $TWST's underperformance: slowdown in synbio growth is driven by funding cuts Looks like the synbio business is dependent on research spending - so when NIH funding is cut synbio feels the pinch πŸ˜–"  
[X Link](https://x.com/TohJah7809/status/1960380523198414937) [@TohJah7809](/creator/x/TohJah7809) 2025-08-26T16:35Z 2059 followers, XXX engagements


"$TWST Twist x Synthetic Design Lab (SDL) Twist collab w/ SDL work on ADCs πŸ₯ΌπŸ”¬πŸ§«πŸ§ͺπŸ¦ πŸ§¬πŸ’»πŸ§‘πŸ”¬πŸ€’πŸŒ‘πŸ’‰πŸ©ΈπŸ©ΉπŸ’ŠπŸ˜·πŸ©ΊπŸ₯βš•"  
[X Link](https://x.com/TohJah7809/status/1964254712783675560) [@TohJah7809](/creator/x/TohJah7809) 2025-09-06T09:09Z 2059 followers, 1020 engagements


"Arks Research: Breakthroughs In Multiomics Sequencing Are Narrowing The Gap Between Cost And Complexity $ARKG $PACB $ILMN πŸ₯ΌπŸ”¬πŸ§«πŸ§ͺπŸ¦ πŸ§¬πŸ’»πŸ§‘πŸ”¬πŸ€’πŸŒ‘πŸ’‰πŸ©ΈπŸ©ΉπŸ’ŠπŸ˜·πŸ©ΊπŸ₯βš•"  
[X Link](https://x.com/TohJah7809/status/1980627625266803170) [@TohJah7809](/creator/x/TohJah7809) 2025-10-21T13:29Z 2059 followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@TohJah7809 Avatar @TohJah7809 TohJah

TohJah posts on X about $twst, $zlab, meituan, china the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

  • X Week XXXXX -XX%
  • X Month XXXXXX -XX%
  • X Months XXXXXXX +38%
  • X Year XXXXXXX +87%

Mentions: XX #

Mentions Line Chart

  • X Week XX +9.10%
  • X Month XX -XX%
  • X Months XXX +4.30%
  • X Year XXX +178%

Followers: XXXXX #

Followers Line Chart

  • X Week XXXXX no change
  • X Month XXXXX +0.34%
  • X Months XXXXX +17%
  • X Year XXXXX +24%

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence stocks XXX% countries XXXX% technology brands XXXX% finance XXXX% cryptocurrencies XXXX% travel destinations XXXX%

Social topic influence $twst #12, $zlab #6, meituan 2.44%, china 2.44%, $pacb 2.44%, $rxrx 1.63%, $absi 1.63%, $arkg #10, $atai #35, $crbu XXXX%

Top accounts mentioned or mentioned by @twistbioscience @biotech2k1 @joe80398726 @3primeanalytica @biopharmiq @davidinglestv @ascptjournals @mdandersonnews @aacr @duedoctor @acquiredfm @cirakue @elilillyandco @timopler @jessiechimni @ceo_culley

Top assets mentioned Twist Bioscience Corporation Common Stock (TWST) Pacific Biosciences of California, Inc. (PACB) Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) ATAI Life Sciences (ATAI) 10x Genomics, Inc. Class A Common Stock (TXG) Tempus AI, Inc. Class A Common Stock (TEM) Schrodinger, Inc. Common Stock (SDGR) Pfizer, Inc. (PFE) Vertex Protocol (VRTX) Amgen, Inc. (AMGN) Revolution Medicines, Inc. Common Stock (RVMD) Synthetify (SNY) Illumina, Inc. (ILMN)

Top Social Posts #


Top posts by engagements in the last XX hours

"Meituan (3690 HK): credit valuation after Q2 results"
X Link @TohJah7809 2023-08-25T12:26Z 2060 followers, XXX engagements

"China tech credit research: Meituan 3690 HK"
X Link @TohJah7809 2024-03-31T17:03Z 2060 followers, XXX engagements

"Ark's weekly bio commentaries: $AKRG $PACB $TXG $TEM $RXRX $ABSI $SDGR Techbio stocks rallied on FDA's animal testing news - guidelines updated to rely less on animal testing and more on AI organoids + international human data beginning w/ biologics e.g. monoclonal antibodies πŸ₯ΌπŸ”¬πŸ§«πŸ§ͺπŸ¦ πŸ§¬πŸ’»πŸ§‘πŸ”¬πŸ€’πŸŒ‘πŸ’‰πŸ©ΈπŸ©ΉπŸ’ŠπŸ˜·πŸ©ΊπŸ₯βš•"
X Link @TohJah7809 2025-04-12T09:24Z 2059 followers, 1612 engagements

"$ZLAB TIVDAK (tisotumab vedotin-tftv) approved in HK This is $GMAB and $PFE's ADC for recurrent or metastatic cervical cancer Approved by the FDA is the US in Apr 2024 Now approved in HK Under review in mainland China Zai Lab has exclusive license from Pfizer in Greater China (CN HK TW MO) πŸ₯ΌπŸ”¬πŸ§«πŸ§ͺπŸ¦ πŸ§¬πŸ’»πŸ§‘πŸ”¬πŸ€’πŸŒ‘πŸ’‰πŸ©ΈπŸ©ΉπŸ’ŠπŸ˜·πŸ©ΊπŸ₯βš•"
X Link @TohJah7809 2025-09-06T09:05Z 2060 followers, XXX engagements

"Ark's weekly bio commentaries: $ARKG $QSI $RXRX $ABSI $PSNL $ATAI (next tweet) πŸ₯ΌπŸ”¬πŸ§«πŸ§ͺπŸ¦ πŸ§¬πŸ’»πŸ§‘πŸ”¬πŸ€’πŸŒ‘πŸ’‰πŸ©ΈπŸ©ΉπŸ’ŠπŸ˜·πŸ©ΊπŸ₯βš•"
X Link @TohJah7809 2025-10-20T10:08Z 2059 followers, 1369 engagements

"Zai Lab partner news: Vertex kidney portfolio updates πŸ‘‡πŸ‘€ $VRTX $ZLAB πŸ₯ΌπŸ”¬πŸ§«πŸ§ͺπŸ¦ πŸ§¬πŸ’»πŸ§‘πŸ”¬πŸ€’πŸŒ‘πŸ’‰πŸ©ΈπŸ©ΉπŸ’ŠπŸ˜·πŸ©ΊπŸ₯βš•"
X Link @TohJah7809 2025-09-27T08:59Z 2060 followers, XXX engagements

"@3primeAnalytica Heres a matcha shop in Japan: how does the price compare to London 🍡"
X Link @TohJah7809 2025-10-20T06:17Z 2059 followers, XX engagements

"A few bios' anchor investors: $TWST: Artisan XXX% $RLAY: Point72 Commodore XXX% each $SANA: ARCH XX% Flagship XX% $FATE: Redmile XXXX% $CRBU: CEO Rachel X% 😍 $IPSC: Versant XX% $PACB: Madrone + Shimoda (Walmart scion) XXX% $ZLAB: Qiming X% πŸ₯ΌπŸ”¬πŸ§«πŸ§ͺπŸ¦ πŸ§¬πŸ’»πŸ§‘πŸ”¬πŸ€’πŸŒ‘πŸ’‰πŸ©ΈπŸ©ΉπŸ’ŠπŸ˜·πŸ©ΊπŸ₯βš•"
X Link @TohJah7809 2025-08-23T15:46Z 2058 followers, 3075 engagements

"$ZLAB news from $AMGN: bemarituzumab (anti FGFR2b) combo w/ chemo for 1L gastric cancer: FORTITUDE-101 p3 trial completed Final analysis OS less than interim analysis πŸ˜±πŸ˜΅πŸ’« Zai Lab will wait for FORTITUDE-102 results: bemarituzumab + Nivolumab/ Opdivo + chemo combo (expected end 2025 or 2026 H1) $ZLAB stock -X% for the week: dipped on this news then partially bounced yesterday $AMGN flat for the week ( $XBI +6% 🦾) πŸ₯ΌπŸ”¬πŸ§«πŸ§ͺπŸ¦ πŸ§¬πŸ’»πŸ§‘πŸ”¬πŸ€’πŸŒ‘πŸ’‰πŸ©ΈπŸ©ΉπŸ’ŠπŸ˜·πŸ©ΊπŸ₯βš•"
X Link @TohJah7809 2025-09-06T10:33Z 2058 followers, XXX engagements

"$TWST x Element Bio collab top-up πŸ‘‡πŸ‘€ πŸ₯ΌπŸ”¬πŸ§«πŸ§ͺπŸ¦ πŸ§¬πŸ’»πŸ§‘πŸ”¬πŸ€’πŸŒ‘πŸ’‰πŸ©ΈπŸ©ΉπŸ’ŠπŸ˜·πŸ©ΊπŸ₯βš•"
X Link @TohJah7809 2025-10-11T11:08Z 2059 followers, XXX engagements

"$TWST Announces Publication in Science Examining Biosecurity Screening Practices in AI-assisted Protein Design πŸ₯ΌπŸ”¬πŸ§«πŸ§ͺπŸ¦ πŸ§¬πŸ’»πŸ§‘πŸ”¬πŸ€’πŸŒ‘πŸ’‰πŸ©ΈπŸ©ΉπŸ’ŠπŸ˜·πŸ©ΊπŸ₯βš•"
X Link @TohJah7809 2025-10-11T11:14Z 2059 followers, XXX engagements

"The FDAs National Priority Voucher pilot X programmes πŸ‘‡πŸ½πŸ‘€ $SNY $RVMD πŸ₯ΌπŸ”¬πŸ§«πŸ§ͺπŸ¦ πŸ§¬πŸ’»πŸ§‘πŸ”¬πŸ€’πŸŒ‘πŸ’‰πŸ©ΈπŸ©ΉπŸ’ŠπŸ˜·πŸ©ΊπŸ₯βš•"
X Link @TohJah7809 2025-10-16T23:55Z 2059 followers, XXX engagements

"China tech credit research: Meituan (ticker: 3690 HK) $11.8b cash low gross leverage: 2.1x Stock trading at HK$114.7 US$92b market cap Largest food delivery + top X hotel & travel booking company in China Sub-HK$90-100 would be πŸ˜‹"
X Link @TohJah7809 2024-06-15T09:52Z 2059 followers, XXX engagements

"My own narrative on $TWST's underperformance: slowdown in synbio growth is driven by funding cuts Looks like the synbio business is dependent on research spending - so when NIH funding is cut synbio feels the pinch πŸ˜–"
X Link @TohJah7809 2025-08-26T16:35Z 2059 followers, XXX engagements

"$TWST Twist x Synthetic Design Lab (SDL) Twist collab w/ SDL work on ADCs πŸ₯ΌπŸ”¬πŸ§«πŸ§ͺπŸ¦ πŸ§¬πŸ’»πŸ§‘πŸ”¬πŸ€’πŸŒ‘πŸ’‰πŸ©ΈπŸ©ΉπŸ’ŠπŸ˜·πŸ©ΊπŸ₯βš•"
X Link @TohJah7809 2025-09-06T09:09Z 2059 followers, 1020 engagements

"Arks Research: Breakthroughs In Multiomics Sequencing Are Narrowing The Gap Between Cost And Complexity $ARKG $PACB $ILMN πŸ₯ΌπŸ”¬πŸ§«πŸ§ͺπŸ¦ πŸ§¬πŸ’»πŸ§‘πŸ”¬πŸ€’πŸŒ‘πŸ’‰πŸ©ΈπŸ©ΉπŸ’ŠπŸ˜·πŸ©ΊπŸ₯βš•"
X Link @TohJah7809 2025-10-21T13:29Z 2059 followers, XXX engagements

@TohJah7809
/creator/twitter::TohJah7809